|
News From The Journal Of The National Cancer Institute, August 26 2008 (Medical News Today)
Novel Trial Design Aims to Speed Drug Development Researchers propose a novel multi-arm trial design that can test several therapies simultaneously and could speed drug development in cancer. Scientists have gained important insights into the biological underpinnings of cancer, but this knowledge has not led to a jump in the number of therapies approved for clinical use.
us.rd.yahoo.com
Natural Chemical From Sea Sponges Induces Death In Cancer Cells Via Unusual Pathway (Science Daily)
A chemical called candidaspongiolide (CAN) inhibits protein synthesis but also kills cancer cells by triggering caspase 12-dependent programmed cell death, according to an article in the Aug. 26 online issue of the Journal of the National Cancer Institute.
us.rd.yahoo.com
Greater Risk Of Cancers Associated With History Of Nonmelanoma Skin Cancer (Medical News Today)
Individuals with a history of nonmelanoma skin cancer (NMSC) are at increased risk for other cancers, according to a study published in the August 26 online issue of the Journal of the National Cancer Institute.
us.rd.yahoo.com
Link Between Angiotensin Inhibitors, Receptor Blockers And Lower Risk Of Nonmelanoma Skin Cancer (Medical News Today)
The use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) was associated with a reduced risk of basal cell or squamous cell skin cancers in U.S. veterans, researchers report in the August 26 online issue of the Journal of the National Cancer Institute. ACE inhibitors and ARBs are frequently prescribed medications for the treatment of high blood pressure.
us.rd.yahoo.com
History Of Nonmelanoma Skin Cancer Is Associated With Increased Risk For Subsequent Malignancies (Science Daily)
Individuals with a history of nonmelanoma skin cancer are at increased risk for other cancers, according to a study published in the Aug. 26 online issue of the Journal of the National Cancer Institute.
us.rd.yahoo.com
Angiotensin Inhibitors And Receptor Blockers Linked To Lower Risk Of Nonmelanoma Skin Cancer (Science Daily)
The use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers was associated with a reduced risk of basal cell or squamous cell skin cancers in US veterans, researchers report in the Aug. 26 online issue of the Journal of the National Cancer Institute.
us.rd.yahoo.com
Heart Risk Due To Low Radiation Doses Worth Investigating Say Scientists (Medical News Today)
Scientists at the National Cancer Institute in the US say more research is needed into the effects of low-dose radiation on cardiovascular risk, an area that remains controversial and about which there is too much uncertainty to give reliable estimates of numbers affected, compared to the well documented risks of cancer from radiation exposure.
us.rd.yahoo.com
Cancer Patients Are Kept In The Dark Surrounding Treatments Awaiting NICE Approval, UK (Medical News Today)
One in four doctors choose not to discuss life extending cancer treatments that are awaiting NICE (National Institute for Health and Clinical Excellence) approval with their patients.
us.rd.yahoo.com
Novel Trial Design Aims To Speed Drug Development (Science Daily)
Researchers propose a novel multi-arm trial design that can test several therapies simultaneously and could speed drug development in cancer, according to an article in the Aug. 26 online issue of the Journal of the National Cancer Institute.
us.rd.yahoo.com
History of nonmelanoma skin cancer is associated with increased risk for subsequent malignancies (EurekAlert!)
( Journal of the National Cancer Institute ) Individuals with a history of nonmelanoma skin cancer are at increased risk for other cancers, according to a study published in the Aug. 26 online issue of the Journal of the National Cancer Institute.
us.rd.yahoo.com
|
